3D Plasmonic Biosensor for Low-Concentration Optical Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing plasmonic biosensors face challenges in detecting hazardous substances and biomolecules at very low concentrations, requiring complex and costly laboratory procedures, limited interaction surface areas, and high fabrication costs, which hinder sensitivity and selectivity.
Innovation Solution
A method and device utilizing plasmonic nanostructures that emit radiation through non-radiative plasmon resonance modes, allowing for differential measurement of light properties under on- and off-resonance conditions to detect and quantify chemical and biological agents, with a 3-D free-form design and low-cost fabrication.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional plasmonic biosensors use absorption spectroscopy or total internal reflection arrangements, then detection capability is achieved, but the devices require complex and costly laboratory procedures, high capital cost instrumentation, and limited interaction surface areas
Solution Approach 1:
The patent replaces complex mechanical/optical systems (total internal reflection arrangements, orthogonal prisms, spectroscopic analysis instruments) with a simpler plasmonic resonance-based system using 3D nanostructures that directly convert chemical/biological interactions into measurable optical signals, eliminating the need for complex laboratory instrumentation
Solution Approach 2:
The patent transitions from 2D planar surfaces to 3D nanostructures with free-form surfaces, increasing the interaction surface area and enabling more effective plasmonic resonance. This dimensional change allows for enhanced sensitivity without requiring complex multi-component systems
2Reliability
If conventional biosensors use label-free spectral absorption, then detection is achieved, but the detectivity is reduced and requires complex chemical functionalization processes for amplification
Solution Approach 1:
The patent changes the fundamental detection parameter from absorption intensity to emitted radiation intensity under plasmonic resonance conditions. This parameter change inherently provides signal amplification without requiring complex chemical functionalization or labeling processes, as the 3D plasmonic nanostructures themselves generate the enhanced signal
3Productivity
If conventional methods use small spatial extend interaction regions in optical waveguides or microring resonators, then integrated device fabrication is achieved, but the sensitivity and selectivity are limited
Solution Approach 1:
The patent employs 3D nanostructures with extended surface areas and complex geometries that provide larger interaction regions compared to planar waveguide surfaces. This three-dimensional configuration maintains integrability while significantly enhancing sensitivity and selectivity through increased analyte-nanostructure interaction volume
Solution Approach 2:
The patent integrates plasmonic nanostructures within optical waveguide or microring resonator systems, creating a nested configuration where the 3D nanostructures are positioned within or on the surface of the integrated photonic device, combining the benefits of both approaches
4Measurement precision
If conventional nanohole biosensors use extraordinary optical transmission, then detection is achieved, but the fabrication requires very high cost methods such as electron-beam or ion-beam lithography
Solution Approach 1:
The patent changes the detection mechanism from relying on transmission through nanoholes to utilizing emitted radiation from plasmonic resonance in 3D nanostructures. This parameter change enables the use of simpler, lower-cost fabrication methods such as standard lithography or self-assembly techniques, eliminating the need for expensive electron-beam or ion-beam lithography
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables fast, accurate, and sensitive detection of toxins and biological agents at low concentrations without complex labeling processes, offering high sensitivity and selectivity with reduced operational costs.
Implementation Method 1
the nanostructure is forced to plasmonic resonance and emits radiation by its non-radiative plasmon resonance modes
Implementation Method 2
The interaction of optical radiation with nanoparticles of mainly noble metals results in the coupled vibration of the electron plasma that defines the physical concept of 'plasmon'. The Localized Surface Plasmon Resonance (LSPR) is achieved in a specific spectral region and results in absorption of radiation.
Data Source
Figure 1A~1B
Figure 2A~2B
Figure 3A~3D
AI summary
Method for the detection with high accuracy, sensitivity and selectivity of chemical and biological agents, wherein an exogenous chemical and/or biological agent is trapped in a plasmonic nanostructure and changes its physical and/or chemical environment, so that upon optical interrogation with radiation of distinct wavelengths and polarization properties, the nanostructure is forced to emit optical radiation from non-radiative plasmon resonance modes, thereby altering the properties of the transmitted, reflected and diffracted radiation. The differential variation of any property of the light constitutes the measurable signal for the quantification of the chemical/biological agent to be detected. Also provided is a plasmonic radiation biosensor device for implementing the method, incorporating a free-form free-space or optical waveguide sensor head equipped with designed three-dimensional plasmonic diffractive nanostructures of large surface area and free stereometric form, or multiple nanostructures, incorporating molecular or atomic functionalizers capable of trapping and detecting the chemical/biological agent through the propagation and/or reflection and/or diffraction of optical radiation.